Swiss Stem Cells Biotech, Pioneers in Regenerative Medicine.

Swiss Biotech Company

Swiss Stem Cells Biotech was founded in 2005 by a group of forward-thinking researchers and physicians working at Cardiocentro Ticino in Lugano, Switzerland. Ever since the first stem cell transplant was performed in 2004 following a heart attack, there had been a conviction that stem cells would be the future of medicine.

Thus, it had been discovered that the umbilical cord was a rich source of stem cells that could become a great resource for the future unborn child and the entire family unit.

Mission

Our mission is to open new frontiers through the collection, treatment, and preservation of stem cells from umbilical cord blood and tissue, placental tissue, and adult adipose tissue for future use. Constantly engaged in research to promote the development of regenerative medicine. We carry out our work following the highest quality standards in the world, which ensure that samples are properly stored and can be used in any transplant center worldwide. We offer our clients a highly specialized, safe, efficient and state-of-the-art service.

RELIABILITY

Certifications

Swiss Stem Cells Biotech was the first biobank in Europe and is the only one in Switzerland to be FACT-NetCord and GMP certified.
To date, more than 70 percent of all transplants are performed with samples from FACT-NetCord certified banks. This certification ensures that samples are considered safe and usable by all transplant centers anywhere in the world.

Vision

Our commitment at SSCB goes far beyond mere stem cell preservation. We are constantly working to inform and involve parents and specialists in the field, because we believe their role is criucial to achieving effective results. We want to be not only the first choice for stem cell preservation, but also a benchmark and an exemplary model for other biobanks.

The important certifications we have obtained testify to our commitment to the highest quality and sustainability. But we are not stopping there. Our goal is to actively contribute to advances in the transplantation of cellular products, offering solutions for a wide range of diseases. We continue to cultivate research collaborations, always within the framework of sustainability and innovation.

We look beyond national borders, providing a global network of research, development and partnerships. We want to offer people the opportunity to store their own stem cells and access therapeutic options in regenerative medicine. In this way, we not only help protect their future, but work together to constantly advance the field of medical science.

Our Story

Innovation since 2005

2021
Opening of new offices in Zurich and Madrid, Spain
2021
2020
New offices in Milan and Rome

. GMP approval of new plant with isolators
2020
2019
SSCB becomes the only Biobank to collaborate in the public-private hybrid banking project.

SSCB is the only private Biobank registered with the World Marrow Donor Association (WMDA) and certified as having all the requirements to process samples from stem cell donations and make them available again.

Approval of a stem cell sample from umbilical cord blood for the treatment of cerebral palsy at Duke University in Durham, North Carolina (USA)
2019
2017
Relocation to the new headquarters in Vacallo, designed and approved to house facilities and services for the pharmaceutical industry.
2017
2016
The autologous use of a stem cell sample from blood cord umbilical in Italy as life-saving therapy for a child with leukemia after chemotherapy failure
2016
2015
Swissmedic certification of adipose tissue

First release of SVF for homologous autologous treatment
2015
2014
Validation of adipose tissue stem cell extraction protocols (SVF - Vascular Stromal Fraction)
2014
2012
SSCB earns prestigious FACT- NETCORD accreditation
2012
2010
Treatment of cerebral palsy in a child with stem cells at the University Hospital of Monterrey (MX)
2010
2009
Recruiting a child for the treatment of cerebral palsy with stem cells
2009
2005
Cardiocentro Ticino Spin Off Authorization.
2005

INTERNATIONAL PRESENCE

Our locations

Swiss Headquarters

Our headquarters is strategically located in Zurich, in the commercial heart of Switzerland.

 

SSCB Headquarter

Dreikönigstrasse 31A
8002 Zürich (CH)

Biobank and laboratory

With SSCB, the samples stay in Switzerland and then go directly from the delivery room to the laboratory for processing and storage in liquid nitrogen.
All in one place. Minimal transport time to ensure maximum safety.

SSCB Biobank and Laboratory

Via Pizzamiglio 12
6833 Vacallo (CH)

Italian Headquarters

Available to Italian and international clients, we also boast an office located in the heart of Italy, in Rome.

Italy Headquarter

Via Giulio Vincenzo Bona 133
00156 Roma (IT)